Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label comparison of Stribild versus Truvada + Kaletra for HIV post-exposure prophylaxis
2014-001193-34Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Stribild arm with Truvada + Kaletra arm (2 arms). Primary endpoint: Dropout rate. Started Jul 2014; status: completed.
02
Drugs
emtricitabine + elvitegravir + cobicistat + tenofovir disoproxilemtricitabine + tenofovir disoproxillopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-001193-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001193-34.